Literature DB >> 28035628

Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.

Youngbin Baek1, Nripen Singh2, Abhiram Arunkumar2, Andrew L Zydney3.   

Abstract

PURPOSE: Histidine is a commonly used buffer in formulation of monoclonal antibodies (mAb), often with excipients like sucrose. The objective of this study was to examine the effects of both histidine and sucrose on the biophysical characteristics of a mAb.
METHODS: The hydrodynamic radius of the mAb was determined by dynamic light scattering and confirmed by size exclusion chromatography. Data were also obtained for the osmotic virial coefficients (from osmotic pressure measurements), the solution viscosity, and the mAb thermal stability (using differential scanning calorimetry) at selected conditions.
RESULTS: There were no significant changes in mAb conformation / stability as determined by DSC. The hydrodynamic radius initially increased with increasing histidine concentration, going through a maximum at a histidine concentration of about 20 mM. The addition of sucrose increased the mAb hydrodynamic radius at all histidine concentrations by about 0.5 nm. The observed effects of histidine and sucrose on the hydrodynamic radius were also reflected in changes in the osmotic pressure and solution viscosity.
CONCLUSIONS: These results provide important insights into the effects of both histidine and sucrose on the behavior of concentrated mAb solutions, including the potential impact on ultrafiltration / diafiltration processes.

Entities:  

Keywords:  excipients; formulation; light scattering; monoclonal antibody; physical characterization

Mesh:

Substances:

Year:  2016        PMID: 28035628     DOI: 10.1007/s11095-016-2092-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release.

Authors:  Wim Jiskoot; Theodore W Randolph; David B Volkin; C Russell Middaugh; Christian Schöneich; Gerhard Winter; Wolfgang Friess; Daan J A Crommelin; John F Carpenter
Journal:  J Pharm Sci       Date:  2011-12-14       Impact factor: 3.534

Review 2.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

3.  Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Naoyuki Kishi; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2011-08-19       Impact factor: 4.200

4.  Evaluation of etanercept stability as exposed to various sugars with biophysical assessment.

Authors:  Dae Gon Lim; Nam Ah Kim; Jun Yeul Lim; Ki Hyun Kim; Shavron Hada; Seong Hoon Jeong
Journal:  Int J Pharm       Date:  2014-09-28       Impact factor: 5.875

5.  Stabilization of protein structure by sugars.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

6.  Biophysical stability of hyFc fusion protein with regards to buffers and various excipients.

Authors:  Jun Yeul Lim; Nam Ah Kim; Dae Gon Lim; Chang-yong Eun; Donghoon Choi; Seong Hoon Jeong
Journal:  Int J Biol Macromol       Date:  2016-02-03       Impact factor: 6.953

7.  Increased thermal stability of proteins in the presence of sugars and polyols.

Authors:  J F Back; D Oakenfull; M B Smith
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

8.  Determination of glomerular size-selectivity in the normal rat with Ficoll.

Authors:  J D Oliver; S Anderson; J L Troy; B M Brenner; W H Deen
Journal:  J Am Soc Nephrol       Date:  1992-08       Impact factor: 10.121

9.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.

Authors:  Branden A Salinas; Hasige A Sathish; Steven M Bishop; Nick Harn; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

10.  The multiple roles of histidine in protein interactions.

Authors:  Si-Ming Liao; Qi-Shi Du; Jian-Zong Meng; Zong-Wen Pang; Ri-Bo Huang
Journal:  Chem Cent J       Date:  2013-03-01       Impact factor: 4.215

View more
  4 in total

1.  A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant 89Zr-immuno-PET agents.

Authors:  Nikunj B Bhatt; Darpan N Pandya; Stephanie Rideout-Danner; Howard D Gage; Frank C Marini; Thaddeus J Wadas
Journal:  Dalton Trans       Date:  2018-09-04       Impact factor: 4.390

2.  Understanding the Stabilizing Effect of Histidine on mAb Aggregation: A Molecular Dynamics Study.

Authors:  Suman Saurabh; Cavan Kalonia; Zongyi Li; Peter Hollowell; Thomas Waigh; Peixun Li; John Webster; John M Seddon; Jian R Lu; Fernando Bresme
Journal:  Mol Pharm       Date:  2022-08-10       Impact factor: 5.364

Review 3.  In silico prediction of post-translational modifications in therapeutic antibodies.

Authors:  Shabdita Vatsa
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

4.  Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.

Authors:  Mathieu Ferrari; Leila Mekkaoui; F Tudor Ilca; Zulaikha Akbar; Reyisa Bughda; Katarina Lamb; Katarzyna Ward; Farhaan Parekh; Rajeev Karattil; Christopher Allen; Philip Wu; Vania Baldan; Giada Mattiuzzo; Emma M Bentley; Yasuhiro Takeuchi; James Sillibourne; Preeta Datta; Alexander Kinna; Martin Pule; Shimobi C Onuoha
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.